Humberto Parada1,2, Xuezheng Sun3, Chiu-Kit Tse3, Andrew F Olshan3,4, Melissa A Troester3,4, Kathleen Conway3,4. 1. Department of Epidemiology, University of North Carolina at Chapel Hill, McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC, 27599, USA. hparada@live.unc.edu. 2. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. hparada@live.unc.edu. 3. Department of Epidemiology, University of North Carolina at Chapel Hill, McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC, 27599, USA. 4. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Abstract
PURPOSE: To examine racial differences in smoking rates at the time of breast cancer diagnosis and subsequent survival among African American and non-African American women in the Carolina Breast Cancer Study (Phases I/II), a large population-based North Carolina study. METHODS: We interviewed 788 African American and 1,020 Caucasian/non-African American women diagnosed with invasive breast cancer from 1993 to 2000, to assess smoking history. After a median follow-up of 13.56 years, we identified 717 deaths using the National Death Index; 427 were breast cancer-related. We used Cox regression to examine associations between self-reported measures of smoking and breast cancer-specific survival within 5 years and up to 18 years after diagnosis conditional on 5-year survival. We examined race and estrogen receptor status as potential modifiers. RESULTS: Current (vs never) smoking was not associated with 5-year survival; however, risk of 13 year conditional breast cancer-specific mortality was elevated among women who were current smokers at diagnosis (HR 1.54, 95% CI 1.06-2.25), compared to never smokers. Although smoking rates were similar among African American (22.0%) and non-African American (22.1%) women, risk of breast cancer-specific mortality was elevated among African American (HR 1.69, 95% CI 1.00-2.85), but only weakly elevated among non-African American (HR 1.22, 95% CI 0.70-2.14) current (vs. never) smokers (P Interaction = 0.30). Risk of breast cancer-specific mortality was also elevated among current (vs never) smokers diagnosed with ER- (HR 2.58, 95% CI 1.35-4.93), but not ER+ (HR 1.11, 95% CI 0.69-1.78) tumors (P Interaction = 0.17). CONCLUSIONS: Smoking may negatively impact long-term survival following breast cancer. Racial differences in long-term survival, as related to smoking, may be driven by ER status, rather than by differences in smoking patterns.
PURPOSE: To examine racial differences in smoking rates at the time of breast cancer diagnosis and subsequent survival among African American and non-African American women in the Carolina Breast Cancer Study (Phases I/II), a large population-based North Carolina study. METHODS: We interviewed 788 African American and 1,020 Caucasian/non-African American women diagnosed with invasive breast cancer from 1993 to 2000, to assess smoking history. After a median follow-up of 13.56 years, we identified 717 deaths using the National Death Index; 427 were breast cancer-related. We used Cox regression to examine associations between self-reported measures of smoking and breast cancer-specific survival within 5 years and up to 18 years after diagnosis conditional on 5-year survival. We examined race and estrogen receptor status as potential modifiers. RESULTS: Current (vs never) smoking was not associated with 5-year survival; however, risk of 13 year conditional breast cancer-specific mortality was elevated among women who were current smokers at diagnosis (HR 1.54, 95% CI 1.06-2.25), compared to never smokers. Although smoking rates were similar among African American (22.0%) and non-African American (22.1%) women, risk of breast cancer-specific mortality was elevated among African American (HR 1.69, 95% CI 1.00-2.85), but only weakly elevated among non-African American (HR 1.22, 95% CI 0.70-2.14) current (vs. never) smokers (P Interaction = 0.30). Risk of breast cancer-specific mortality was also elevated among current (vs never) smokers diagnosed with ER- (HR 2.58, 95% CI 1.35-4.93), but not ER+ (HR 1.11, 95% CI 0.69-1.78) tumors (P Interaction = 0.17). CONCLUSIONS: Smoking may negatively impact long-term survival following breast cancer. Racial differences in long-term survival, as related to smoking, may be driven by ER status, rather than by differences in smoking patterns.
Entities:
Keywords:
Breast cancer; Mortality; Smoking; Survival analysis
Authors: Eboneé N Butler; Chiu-Kit Tse; Mary Elizabeth Bell; Kathleen Conway; Andrew F Olshan; Melissa A Troester Journal: Cancer Causes Control Date: 2016-05-06 Impact factor: 2.506
Authors: Philippe Bertheau; Jacqueline Lehmann-Che; Mariana Varna; Anne Dumay; Brigitte Poirot; Raphaël Porcher; Elisabeth Turpin; Louis-François Plassa; Anne de Roquancourt; Edwige Bourstyn; Patricia de Cremoux; Anne Janin; Sylvie Giacchetti; Marc Espié; Hugues de Thé Journal: Breast Date: 2013-08 Impact factor: 4.380
Authors: Ahmed Jamal; Brian A King; Linda J Neff; Jennifer Whitmill; Stephen D Babb; Corinne M Graffunder Journal: MMWR Morb Mortal Wkly Rep Date: 2016-11-11 Impact factor: 17.586
Authors: Mia M Gaudet; Susan M Gapstur; Juzhong Sun; W Ryan Diver; Lindsay M Hannan; Michael J Thun Journal: J Natl Cancer Inst Date: 2013-02-28 Impact factor: 13.506
Authors: Sharon K Sagiv; Mia M Gaudet; Sybil M Eng; Page E Abrahamson; Sumitra Shantakumar; Susan L Teitelbaum; Julie A Britton; Paula Bell; Joyce A Thomas; Alfred I Neugut; Regina M Santella; Marilie D Gammon Journal: Ann Epidemiol Date: 2007-03-28 Impact factor: 3.797
Authors: Luigino Dal Maso; Antonella Zucchetto; Renato Talamini; Diego Serraino; Carmen F Stocco; Marina Vercelli; Fabio Falcini; Silvia Franceschi Journal: Int J Cancer Date: 2008-11-01 Impact factor: 7.396
Authors: Michael N Passarelli; Polly A Newcomb; John M Hampton; Amy Trentham-Dietz; Linda J Titus; Kathleen M Egan; John A Baron; Walter C Willett Journal: J Clin Oncol Date: 2016-01-25 Impact factor: 44.544
Authors: Esther M John; Valerie McGuire; Allison W Kurian; Jocelyn Koo; Salma Shariff-Marco; Scarlett Lin Gomez; Iona Cheng; Theresa H M Keegan; Marilyn L Kwan; Leslie Bernstein; Cheryl Vigen; Anna H Wu Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-12-18 Impact factor: 4.090
Authors: Vivian J Bea; Joan E Cunningham; Anthony J Alberg; Dana Burshell; Colleen E Bauza; Kendrea D Knight; Tonya R Hazelton; Heidi Varner; Rita Kramer; Susan Bolick; Deborah Hurley; Catishia Mosley; Marvella E Ford Journal: Front Oncol Date: 2018-09-27 Impact factor: 6.244
Authors: Sarah Darmon; Amie Park; Leann A Lovejoy; Craig D Shriver; Kangmin Zhu; Rachel E Ellsworth Journal: Int J Environ Res Public Health Date: 2022-03-30 Impact factor: 3.390